Tomáš Šimurda/LinkedIn
Jun 16, 2026, 13:49
Tomáš Šimurda: Fibromics Team Secures EHA Innovation Grant for Innovative Research
Tomáš Šimurda, Hematologist at National Center of Hemostasis and Thrombosis, University Lecturer at Jessenius Faculty of Medicine in Martin, shared a post on LinkedIn:
“Honored to receive the 2026 European Hematology Association (EHA) Innovation Grant.
This recognition reflects the strength of international collaboration within the Fibromics consortia together with Alessandro Casini, Giancarlo Castaman, Saskia Schols, and Maartje van den Biggelaar.
Grateful to EHA for supporting innovative research in hematology and to all colleagues and collaborators who contribute to this journey.”
Stay updated with Hemostasis Today.
-
Aug 11, 2026, 04:10Haroun Gajraj: CLaCS vs Sclerotherapy – What Does the Evidence Show
-
Aug 11, 2026, 02:54Tareq Abadl: The Ultimate Guide to Clinically Significant Antibodies
-
Aug 10, 2026, 17:35Chokri Ben Lamine: Balancing Holistic Care and Precision in Hematology
-
Aug 10, 2026, 17:14Anna Stanizzi: Patient Blood Management as a New Model of Personalized Care
-
Aug 10, 2026, 17:12Odong Christopher: New Research on Ischemic Stroke Prediction in Uganda
-
Aug 10, 2026, 16:58Jeff Szer AM: Advancing the Management of Paroxysmal Nocturnal Hemoglobinuria
-
Aug 10, 2026, 16:51Suebsarn Ruksakulpiwat։ A New Milestone in the Development of the Stroke Risk Screening Scales
-
Aug 10, 2026, 16:09Preetie Shetty Akkunje: Making Stroke Rehabilitation Accessible in Low-Resource Settings
-
Aug 10, 2026, 15:50The Next Antithrombotic Frontier: GPVI Inhibitors Beyond Aspirin